Hypogonadism, often referred to as low testosterone in men or ovarian insufficiency in women, is a condition where the body’s sex glands produce little or no hormones. For many, the symptoms of chronic fatigue, reduced muscle mass, low libido, and mood instability can feel like a premature aging process that impacts vitality and self-confidence. It is not merely a lifestyle issue; it is a medical deficiency that can affect bone density and cardiovascular health.

Treatment is essential to restore hormonal balance and alleviate the physical and emotional drain caused by these deficiencies. The goal is to return hormone levels to a physiological range that supports normal body function. Because the condition can occur at birth or develop later in life due to injury, infection, or aging, treatment plans are highly specific. The approach depends heavily on whether the patient wishes to preserve fertility, as some treatments can suppress sperm or egg production (Endocrine Society, 2018).

Overview of treatment options for Hypogonadism

The primary medical approach to hypogonadism is Hormone Replacement Therapy (HRT). The objective is to supplement the hormones that the body is failing to produce naturally. In men, this is Testosterone Replacement Therapy (TRT); in women, it involves estrogen and progesterone therapy.

For men specifically, there is a critical distinction in treatment paths based on fertility goals. If fertility is not a concern, direct testosterone replacement is the standard. However, for men who wish to father children, doctors may choose medications that stimulate the body’s own production of testosterone rather than replacing it externally. While lifestyle factors like weight loss and stress management support recovery, medication is almost always required to correct the underlying hormonal deficit.

Medications used for Hypogonadism

For male hypogonadism, Testosterone Replacement Therapy (TRT) is the first-line treatment. This is available in several delivery methods to suit patient preference and absorption needs:

  • Transdermal Gels and Patches: These are applied daily to the skin (shoulders, arms, or thighs). They provide a steady release of hormones, mimicking the body’s natural daily rhythm.
  • Injections: Testosterone cypionate or enanthate are commonly injected into the muscle every one to two weeks. Longer-acting formulations are also available.
  • Buccal or Nasal Systems: These include patches applied to the gum or gels sprayed into the nostrils multiple times a day.
  • Pellets: Small implants placed under the skin of the hip or buttock that release testosterone slowly over 3 to 6 months.

For men seeking to maintain fertility, or those with secondary hypogonadism, Gonadotropins or SERMs (Selective Estrogen Receptor Modulators) are viable treatments.

  • Human Chorionic Gonadotropin (hCG): An injectable medication that mimics the body’s natural signals to stimulate the testicles to produce both testosterone and sperm.
  • Clomiphene Citrate: While originally for women, this oral medication is frequently used off-label in men to boost natural testosterone production without shrinking the testicles.

Clinical experience suggests that patients typically report improvements in energy and mood within a few weeks, while physical changes like increased muscle mass and libido may take several months (Mayo Clinic, 2023).

How these medications work

Testosterone replacement therapy (TRT) supplements synthetic testosterone to restore normal serum levels, aiding in maintaining bone density, muscle distribution, and red blood cell production. However, the high blood testosterone halts signals to the testicles, potentially causing testicular shrinkage and stopped sperm production.

In contrast, medications like hCG and clomiphene stimulate natural testosterone production. Clomiphene blocks brain estrogen receptors, prompting the pituitary gland to release more Luteinizing Hormone (LH). LH then signals the testicles to produce more testosterone. This mechanism maintains testicular size and function (National Institutes of Health, 2020).

Side effects and safety considerations

TRT requires careful monitoring due to potential side effects like acne, fluid retention, localized skin irritation (gels/patches), and erythrocytosis (excess red blood cells, increasing clot risk). It can also worsen sleep apnea and stimulate prostate growth.

While TRT doesn’t cause prostate cancer, it can stimulate existing cancer cells, making regular prostate screening mandatory for older men. Topical gels should not be transferred to women or children. Patients must seek immediate care for chest pain, shortness of breath, or severe leg swelling (Food and Drug Administration, 2022).

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. Endocrine Society. https://www.endocrine.org
  2. Mayo Clinic. https://www.mayoclinic.org
  3. National Institutes of Health. https://www.nih.gov
  4. Food and Drug Administration. https://www.fda.gov

Medications for Hypogonadism

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hypogonadism.

Found 7 Approved Drugs for Hypogonadism

Follitropin

Brand Names
Follistim, Gonal-f RFF Redi-ject, Gonal-f

Follitropin

Brand Names
Follistim, Gonal-f RFF Redi-ject, Gonal-f
Gonal-F is indicated for: GONAL-F is a gonadotropin indicated for: Women: Induction of ovulation and pregnancy in oligo-anovulatory infertile women for whom the cause of infertility is functional and not due to primary ovarian failure.

Undecanoate

Brand Names
Kyzatrex, Jatenzo, Tlando, Aveed

Undecanoate

Brand Names
Kyzatrex, Jatenzo, Tlando, Aveed
TLANDO is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle stimulating hormone (FSH), luteinizing hormone (LH)) above the normal range [see Dosage and Administration.

Choriogonadotropin

Brand Names
Pregnyl, Ovidrel

Choriogonadotropin

Brand Names
Pregnyl, Ovidrel
Ovidrel ® PreFilled Syringe (choriogonadotropin alfa injection) is indicated for the induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who have been appropriately pretreated with follicle stimulating hormones as part of an Assisted Reproductive Technology (ART) program such as in vitro fertilization and embryo transfer. Ovidrel ® PreFilled Syringe is also indicated for the induction of ovulation (OI) and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure. Selection of Patients Before treatment with gonadotropins is instituted, a thorough gynecologic and endocrinologic evaluation must be performed. This should include an assessment of pelvic anatomy. Patients with tubal obstruction should receive Ovidrel ® PreFilled Syringe only if enrolled in an in vitro fertilization program. Primary ovarian failure should be excluded by the determination of gonadotropin levels. Appropriate evaluation should be performed to exclude pregnancy. Patients in later reproductive life have a greater predisposition to endometrial carcinoma as well as a higher incidence of anovulatory disorders. A thorough diagnostic evaluation should always be performed in patients who demonstrate abnormal uterine bleeding or other signs of endometrial abnormalities before starting FSH and Ovidrel ® PreFilled Syringe therapy. Evaluation of the partner's fertility potential should be included in the initial evaluation.

Xyosted

Generic Name
Enanthate

Xyosted

Generic Name
Enanthate
XYOSTED (testosterone enanthate) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations but have gonadotropins in the normal or low range. Limitations of Use: Safety and efficacy of XYOSTED in males less than 18 years old have not been established [see Use in Specific Populations.

Cypionate

Brand Names
Depo-Estradiol, Depo-Testosterone, Azmiro

Cypionate

Brand Names
Depo-Estradiol, Depo-Testosterone, Azmiro
Testosterone Cypionate Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) - testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. Hypogonadotropic hypogonadism (congenital or acquired) - gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. Safety and efficacy of Testosterone Cypionate Injection in men with “age­-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
Showing 1-5 of 7
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances